Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cancer Research"
DOI: 10.1101/2022.10.24.22281440
Abstract: Purpose: Investigate and compare the use of plasma- and urine DNA mutation analysis for predicting neoadjuvant chemotherapy (NAC) response and long-term oncological outcome in patients with muscle invasive bladder cancer. Experimental Design: Whole exome sequencing… read more here.
Keywords: tddna; dna; plasma; response outcome ... See more keywords
Therapy Response and Outcome Explained by Leukemia Cell of Origin.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-20-1080
Abstract: In this issue of Cancer Discovery, Cai and colleagues delineate a new mechanism that links cell of origin, the transcription factor EVI1, apoptotic priming, and therapeutic susceptibility in mixed lineage leukemia-rearranged acute myeloid leukemia. These… read more here.
Keywords: cell origin; leukemia; outcome explained; therapy response ... See more keywords
Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Veterinary Medical Association"
DOI: 10.2460/javma.254.8.960
Abstract: OBJECTIVE To assess response and outcome in dogs with stage 4 anal sac apocrine gland adenocarcinoma (ASAGA) treated with toceranib phosphate as the sole chemotherapeutic agent. DESIGN Retrospective case series. ANIMALS 15 client-owned dogs with… read more here.
Keywords: stage; response; treatment; anal sac ... See more keywords